ADMA
Adma Biologics Inc
NASDAQ · Biotechnology
$16.43
+0.49 (+3.07%)
Performance
1D
—
1W
-6.11%
1M
-8.37%
3M
+2.50%
6M
-4.48%
1Y
-1.38%
YTD
-8.11%
Open$16.31
Previous Close$15.94
Day High$16.60
Day Low$16.09
52W High$25.67
52W Low$13.50
Volume1.59M
Avg Volume1.98M
Market Cap3.91B
P/E Ratio18.67
EPS$0.85
SectorBiotechnology
Volume Analysis
0.80x average volume
Technical Indicators
SMA 50
$18.40
Below
SMA 200
$17.89
Below
RSI (14)
41.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
9 analysts
Price Target
+114.4% upside
Current
$16.43
$16.43
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 417.09M | 239.65M | 937.52M |
| Net Income | 193.33M | 99.97M | -79,968,646 |
| Profit Margin | 46.4% | 44.0% | -8.5% |
| EBITDA | 134.90M | 73.63M | -111,424,845 |
| Free Cash Flow | — | — | -94,542,550 |
| Rev Growth | +74.0% | +74.0% | +21.3% |
| Debt/Equity | 0.21 | 0.21 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |